Literature DB >> 165645

Cerebrospinal fluid concentration and urinary excretion of cyclic adenosine-3', 5'-monophosphate in various diseases of children.

V V Myllylä, E R Heikkinen, S Similä, E Hokkanen, H Vapaatalo.   

Abstract

Cerebrospinal fluid (CSF) concentration and urinary excretion of cyclic adenosine-3',5'-monophosphate(cAMP) were measured in children aged from 3 days to 15 years by the protein-binding method of Gilman (1970). The mean CSF cAMP concentration (22.4 plus or minus 0.6 (S.E.) nmol/l) of 24 "healthy" children tended to be lower (P less then 0.2) than that of adult patients who revealed no pathological findings on clinical examination. No difference in the results was foung between the sexes. High cAMP concentrations were found in CSF of children suffering from cerebellar glioma, hypothalamic precocious puberty, bacterial meningitis, or Cushing's disease. The urinary excretion of cAMP varied from 0.2 to 5.3 in "healthy" and from 1.3 to 7.6 mumol/24 hrs in diseased children. Two children with pheochromocytoma showed a striking decrease in the rate of urinary excretion of the nucleotide after surgical treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165645     DOI: 10.1007/bf00492331

Source DB:  PubMed          Journal:  Z Kinderheilkd        ISSN: 0044-2917


  15 in total

1.  Cerebrospinal fluid concentration of cyclic adenosine-3',5'-monophosphate and pneumoencephalography.

Authors:  V V Myllylä; H Vapaatalo; E Hokkanen; E R Heikkinen
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

2.  Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.

Authors:  H Cramer; L K Ng; T N Chase
Journal:  Arch Neurol       Date:  1973-09

3.  Urinary excretion and cerebrospinal fluid concentration of cyclic adenosine-3',5'-monophosphate in various neurological diseases.

Authors:  E R Heikkinen; V V Myllylä; H Vapaatalo; E Hokkanen
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

4.  Effect of probenecid on levels of cyclic AMP in human cerebrospinal fluid.

Authors:  H Cramer; L K Ng; T N Chase
Journal:  J Neurochem       Date:  1972-06       Impact factor: 5.372

5.  Urinary cyclic AMP excretion in depression and mania. Effects of levodopa and lithium carbonate.

Authors:  M I Paul; H Cramer; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1971-04

6.  Adenyl cyclase and phosphodiesterase activities in brain areas of man, monkey and rat.

Authors:  R H Williams; S A Little; J W Ensinck
Journal:  Am J Med Sci       Date:  1969-09       Impact factor: 2.378

7.  Effects of probenecid and exercise on cerebrospinal-fluid cyclic A.M.P. in affective illness.

Authors:  H Cramer; F K Goodwin; R M Post; W E Bunney
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

8.  3',5' cyclic adenosine monophosphate in depression and mania.

Authors:  Y H Abdulla; K Hamadah
Journal:  Lancet       Date:  1970-02-21       Impact factor: 79.321

9.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

10.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

View more
  3 in total

1.  Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Authors:  M B Bowers; R E Study
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  Cyclic adenosine-3',5-monophosphate concentration and enzyme activities of cerebrospinal fluid in meningitis of children.

Authors:  E R Heikkinen; S Similä; V V Myllylä; E Hokkanen; H Vapaatalo
Journal:  Z Kinderheilkd       Date:  1975-11-13

3.  Studies on cyclic AMP in different compartments of cerebrospinal fluid.

Authors:  D Tsang; S Lal; T L Sourkes; R M Ford; A Aronoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.